文献速递外周动脉疾病

孤立性腘动脉严重外周动脉疾病的血管腔内治疗:无论治疗方式如何,结局相当

Endovascular Management of Severe Peripheral Artery Disease Isolated to the Popliteal Artery Shows Comparable Outcomes Regardless of Treatment Modality.
PubMed 文献 · Ann Vasc Surg · 2025-03-05

基于血管质量倡议(VQI)数据库2011年1月至2019年12月的数据,纳入1740例孤立性腘动脉闭塞性疾病接受血管腔内治疗的患者,按症状(跛行 vs 慢性肢体威胁性缺血)和术式(普通球囊血管成形术 vs 辅助支架/斑块旋切术)分层。跛行组中辅助支架/斑块旋切术的免截肢生存率在1年和3年显著更高,但多变量分析显示其与免截肢生存改善无独立关联;慢性肢体威胁性缺血组两组无显著差异,再干预率亦无差异。作者认为无论血管腔内治疗方式如何,免截肢生存率相当,并强调需要进一步研究辅助方式治疗复杂病变。

要点

  • 跛行组辅助支架/斑块旋切术1年免截肢生存率94.2% vs 普通球囊88.9%(P=0.03),3年83.0% vs 76.6%(P=0.04)。
  • 多变量分析显示辅助支架/斑块旋切术与免截肢生存改善无独立关联(校正HR 0.74,95%CI 0.48-1.16,P=0.19)。
  • 慢性肢体威胁性缺血组两组免截肢生存率无显著差异(1年65% vs 64.6%,P=0.78;3年47.1% vs 42.6%,P=0.30)。

核心结论

  • 作者认为,在所有孤立性腘动脉闭塞性疾病患者中,无论血管腔内治疗方式如何,免截肢生存率相当。
  • 跛行患者的免截肢生存率优于慢性肢体威胁性缺血患者,且主要由死亡率驱动。
  • 作者强调需要进一步研究辅助方式治疗复杂病变。

研究设计与样本

  • 基于血管质量倡议(VQI)数据库的查询分析,纳入2011年1月至2019年12月接受血管腔内治疗的孤立性腘动脉闭塞性疾病患者。
  • 排除无医疗保险按服务收费资格、同侧肢体既往干预史或除腘动脉外还治疗其他血管的患者。
  • 共1740例患者符合分析标准,按初始症状(跛行 vs 慢性肢体威胁性缺血)和术式(普通球囊血管成形术 vs 辅助支架/斑块旋切术)分层。

主要发现

  • 跛行组中,辅助支架/斑块旋切术的免截肢生存率在1年和3年显著高于普通球囊(1年:94.2% vs 88.9%,P=0.03;3年:83.0% vs 76.6%,P=0.04)。
  • 跛行组中,辅助支架/斑块旋切术的死亡率显著优于普通球囊(1年:4.6% vs 10.2%,P=0.01;3年:15.4% vs 23.3%,P=0.02),而大截肢率无显著差异。
  • 多变量分析显示,辅助支架/斑块旋切术的使用与免截肢生存改善无独立关联(校正HR 0.74,95%CI 0.48-1.16,P=0.19)。
  • 慢性肢体威胁性缺血组中,辅助支架/斑块旋切术与普通球囊的免截肢生存率无显著差异(1年:65% vs 64.6%,P=0.78;3年:47.1% vs 42.6%,P=0.30)。
  • 在跛行或慢性肢体威胁性缺血组中,按辅助治疗使用分层,再干预率无统计学差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者在结论中强调需要进一步研究辅助方式治疗复杂病变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While the use of endovascular intervention for peripheral artery disease has expanded in recent years, there remains relatively few studies focused on the endovascular treatment of isolated popliteal artery occlusive disease. The popliteal artery presents a particular challenge for endovascular intervention due to the constant flexion at the knee. We sought to assess the outcomes for endovascular management of isolated popliteal artery occlusive disease based on type of intervention performed. METHODS: The Vascular Quality Initiative (VQI) database was queried for patients with isolated popliteal artery occlusive disease who underwent endovascular intervention from January 2011 to December 2019. Patients were excluded from analysis if they did not have Medicare Fee-For-Service entitlement, had a history of prior intervention in the ipsilateral limb, or had vessels treated in addition to the popliteal artery. Patients were stratified into groups based on their initial presenting symptom (claudication versus chronic limb-threatening ischemia (CLTI)) and were analyzed by endovascular procedure performed (plain old balloon angioplasty (POBA) versus adjunctive stent/atherectomy). The POBA group underwent only plain balloon angioplasty, whereas the adjunctive stent/atherectomy group underwent any type of balloon angioplasty and adjunctive stenting or atherectomy or both. The primary outcome was amputation-free survival, a composite outcome of freedom from major amputation and/or death. RESULTS: A total of 1,740 patients met criteria for analysis who underwent endovascular intervention for isolated popliteal artery occlusive disease. Among patients with claudication, the amputation-free survival rate was significantly higher at 1 year and 3 years for patients treated with adjunctive stent/atherectomy than POBA (1 year: 94.2% vs. 88.9%, P = 0.03; 3 years: 83.0% vs. 76.6%, P = 0.04). This difference appeared to be driven by mortality, as mortality was significantly better for adjunctive stent/atherectomy than POBA (1 year: 4.6% vs. 10.2%, P = 0.01; 3 years: 15.4% vs. 23.3%, P = 0.02), whereas major amputation rates were not significantly different. However, multivariable analysis showed that use of adjunctive stent/atherectomy was not independently associated with improved amputation-free survival (adjusted hazard ratio 0.74, 95% confidence interval 0.48-1.16, P = 0.19). In the CLTI group, amputation-free survival rates were not significantly different for patients treated with adjunctive stent/atherectomy compared to POBA (1 year: 65% vs. 64.6%, P = 0.78; 3 years: 47.1% vs. 42.6%, P = 0.30). Reintervention rates were not statistically different when stratified by use of adjunctive therapies in either the claudication or CLTI groups. CONCLUSION: Our results suggest that across all patients with isolated popliteal artery occlusive disease, amputation-free survival rates were comparable regardless of endovascular treatment modality. As expected, amputation-free survival for patients presenting with claudication was favorable compared to those with CLTI and was driven primarily by mortality. Reintervention rates were similar across all patients regardless of treatment modality. This study underscores the clinical challenge of treating isolated popliteal artery occlusive disease and stresses the need for further study of adjunctive modalities in treating complex lesions.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Auda ME, Ratner M, Chang H, et al. Endovascular Management of Severe Peripheral Artery Disease Isolated to the Popliteal Artery Shows Comparable Outcomes Regardless of Treatment Modality. Ann Vasc Surg. 2025. PMID: 40054603. doi:10.1016/j.avsg.2025.01.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。